VERSION 1 -REVIEW
With regard to the need for statistical review, one will be needed but not on this draft as there is not enough detail on the statistical plan at this juncture.
A statistical review will be required on the revision if you choose to have them resubmit.
REVIEW RETURNED
03-Apr-2017
GENERAL COMMENTS
This is an important systematic review and will potentially provide valuable information about factors that predict discharge destination following an acute stay for TBI.
The following comments are offered to improve the conceptualization and/or design of the SR.
-I would recommend writing out the PICO questions you wish to answer with this review. It"s not completely clear how the results of this SR will be useful to consumers/clinicians/policy makers. -The 2 nd goal of the SR is to inform optimal referral and discharge plans but this project as currently defined does not provide evidence to inform such a goal. A SR would need to evaluate acute discharge setting as an independent variable and its effects on post-acute outcomes in order to provide evidence on what setting is optimal/effective. -The method notes that only peer-reviewed articles would be used as evidence. I would recommend also searching and including policy reports from groups like Mathematica, CMS, etc., who might have high quality, population-based data and may report on predictive factors. -The introduction notes that IR discharge destination might be used as an acute care quality measure. However, it would seem that matching the right destination to the patient"s needs and wishes might be a more nuanced quality measure (being aware that patient or family preference may not be available in any studies.) -"Lives alone" is a critical factor to study. I would also include relationship of caregiver or similar such measure to the patient if it is available. Environment is also listed as a factor. I would specific if this includes payer system, e.g., factors could be different in Canada"s single-payer system versus the U.S. -I"d make the age range 18 y/o plus or even 21 y/o. At 16 and 17 (maybe 18 too), there are many confounds in terms of the teenager being in school, the parent making the decision, services often being provided in school versus medical/community healthcare settings, education level being confounded (e.g., a 16 y/o with 10 th grade education is different than a 35 y/o with 10 th grade ed.), etc. I don"t think age will be linear in studies where 16 and 17 year olds are included.
-Why will articles that focus on discharge against medical advice be excluded? Could this not be a highly important predictor? -Study selection section needs to be much better defined. This is the most important step in the SR process. -There needs to be a greater elaboration of what missing information would be requested from authors. I would change "missing data" to "missing methodological information". -The authors state that meta-analysis won"t be used due to the heterogeneity in studies. It is unclear to me how heterogeneity would be a problem. If samples are used that have moderate and low levels of bias but somewhat different characteristics, meta-analysis would help pool these samples and produce a more reliable result. Heterogeneity of effect size or precision could impact the modeling approach used but wouldn"t be a deterrent to using meta-analysis. -The authors are using the QUIPS to evaluate bias in prognostic studies. The use of QUIPS really requires having statistical expertise on the SR panel and pre-specification of high, medium, and low bias methods for the type of prognostic questions and statistical analyses used. For example, some thought or documentation of thought already given needs to be provided on requirements for study power and evaluating single factor models versus factors in multivariable models. Will articles using stepwise regression be included given their common use in rehabilitation but their notorious 40% false positive predictor identification rates and inflated ORs (and low CI"s). -Having read the whole article now, my sense is that the author team only partially has the expertise required to successfully conduct this SR. A biostatistician with expertise in multivariable logistic regression and meta-analysis is an absolute requirement. This SR cannot be done successfully without this expertise throughout the SR process. Also, this SR is about how decisions are made in an acute care environment. There does not appear to be acute care discharge decision makers, e.g., trauma MD"s or case managers (preferable with SR experience), on the project. Such decision-making expertise is crucial to interpreting data and drawing conclusions from the evidence.
I hope this feedback is useful as you approach the revision of this SR plan. 1) The chosen age range for the population of interest (>15 years of age) strikes me as a little odd. The cutoff includes older adolescents, many of whom will still be attending high school; this group faces far different demands and functions in a very different context than young adults. I suggest the authors either change the cutoff to >17 years of age or offer some rationale for their chosen cutoff.
REVIEWER
2) The listing of clinical factors that may predict discharge disposition is fairly limited. The authors may want to broaden the score of clinical factors to include clinical assessments and testing, including neuropsychological testing, because such assessments often play an important role in making discharge recommendations.
VERSION 1 -AUTHOR RESPONSE
Thank you for your insightful comments. We have taken your suggestions into consideration and have responded below.
-I would recommend writing out the PICO questions you wish to answer with this review. It"s not completely clear how the results of this SR will be useful to consumers/clinicians/policy makers. Answer: We have structured the questions of this study following PICO methodology: Population (i.e. patients with TBI), Intervention/Prognostic factor (i.e. predictors of discharge destination), comparison (not applicable), Outcome (i.e. discharge destinations including home, inpatient rehab facilities, skilled nursing facilities/other institutions). (page 4)
What are the most common discharge destinations from acute care in patients with TBI? What are the predictors of discharge to any rehabilitation facilities versus home from acute care in patients with TBI? What are the predictors of discharge to IRFs versus SNFs/other institutions from acute care in patients with TBI?
We have also provided a complete description of the advantage of the results of this study for patients, clinicians and policy makers in the conclusion section (page 9).
-The 2nd goal of the SR is to inform optimal referral and discharge plans but this project as currently defined does not provide evidence to inform such a goal. A SR would need to evaluate acute discharge setting as an independent variable and its effects on post-acute outcomes in order to provide evidence on what setting is optimal /effective.
Answer: This sentence was referring to the strength of this study in "the limitation and strength" section. The objective and questions were listed separately in the general objectives and research questions sections. In order to make this sentence clear, it is changed as below in the limitation and strength section: "The results of this study will assist health care providers in discharge planning from acute care."
-The method notes that only peer-reviewed articles would be used as evidence. I would recommend also searching and including policy reports from groups like Mathematica, CMS, etc., who might have high quality, population-based data and may report on predictive factors.
Answer: The search strategy of this study was designed in collaboration with medical experts and specialists in TBI care as well as the librarian at the Toronto Rehabilitation Institute (TRI). It should be noted that in the search strategy that we have attached as an additional file, the research terms were not limited based on the type of studies so we will have the opportunity to find high quality populationbased studies. As part of the search strategy, in addition to search of related database, we will review the reference list of selected articles manually and will search the first 100 results from the three main search terms queries on Google internet search engine to distinguish related studies as well. In this step, we will also search any high-quality population-based studies that may have been missed in the above search strategy. In order to make this section clear we have added "high quality population-based study to the "search strategy" and "type of study" sections. (page 5 and 6) -The introduction notes that IR discharge destination might be used as an acute care quality measure. However, it would seem that matching the right destination to the patient"s needs and wishes might be a more nuanced quality measure (being aware that patient or family preference may not be available in any studies.)
Answer: The primary aim of this study is to review the predictors of different discharge destinations from acute care because clinical priorities and pattern of care will be changed based on the discharge setting. We believe that in order to facilitate the matching of patients" needs and wishes with possible discharge destination, the first step is to identify the predictors of discharge destination from acute care. We expect the results of this study will set the ground work for future studies that will investigate optimal destinations. Although patient and family preference could be one of the factors in the process of discharge planning, we will review all clinical and non-clinical predictors of discharge destinations. The potential predictors that may not be explored in the included studies will be reported as limitations and future directions. We took this comment in to consideration and changed this sentence as below:
"During the last decade, improving quality of care and increasing the number of survivors have gradually shifted the focus of research from discharge status (morbidity or mortality) to that of discharge destination. To use the discharge destination as a measure of clinical priorities and pathway of care, it is important to understand the factors that contribute to this outcome". (page3) We have made this change in the introduction of abstract as well. (page 2) -"Lives alone" is a critical factor to study. I would also include relationship of caregiver or similar such measure to the patient if it is available. Environment is also listed as a factor. I would specific if this includes payer system, e.g., factors could be different in Canada"s single-payer system versus the U.S.
Answer: We will search all clinical and non-clinical factors as the predictor. Social factors (patient and family preference, preinjury location of living, living situation), "clinical assessments" and "discharge against medical advice" were added to the categories of predictors. We will also search payer system under socio-economic status (page 5).
-I"d make the age range 18 y/o plus or even 21 y/o. At 16 and 17 (maybe 18 too), there are many confounds in terms of the teen-ager being in school, the parent making the decision, services often being provided in school versus medical/community healthcare settings, education level being confounded (e.g., a 16 y/o with 10th grade education is different than a 35 y/o with 10th grade ed.), etc. I don"t think age will be linear in studies where 16 and 17 year olds are included.
Answer: In order to be concise in selecting inclusion/exclusion criteria and process of this systematic review we have conducted a pilot study. We have found that various countries have different cut-off points regarding the age of adulthood. In reviewing the results of the pilot study, we opted to allocate the legal age as the cut-off point for age of adulthood (age that patients could give an informed consent independently). Also, we have searched various countries and found that the minimum legal age was 16 years old and therefore, it was chosen for this study. However, with respect to the importance of this comment, we will note the range of age as the potential limitation of this study.
(page 4) http://www.hc-sc.gc.ca/sr-sr/advice-avis/reb-cer/consent/index-eng.php https://firstclinical.com/journal/2008/0806_Consent_Age.pdf -Why will articles that focus on discharge against medical advice be excluded? Could this not be a highly important predictor?
Answer: For the purpose of this study, we will review all clinical and non-clinical predictors. "Discharge against medical advice" could be a possible predictor of discharge destination that will be studied under clinical factors in this systematic review (page 5). However, studies that used "discharge against medical advices" as an outcome measure will be removed from this review because it does not match with objective of this study. In order to make this section clear in the manuscript, this sentence was changed as below:
"Also, articles that focused on "discharge against medical advice" as an outcome measure will be excluded from this study." (page5) All articles that will be excluded from this study will be reported in a separate table and the reasons will be provided accordingly.
-Study selection section needs to be much better defined. This is the most important step in the SR process.
Answer: further explanation has been added to this section:
"All literature from databases will be combined and duplicates will be removed using Endnote X7 software and manually. Titles and abstracts of the remaining articles will be screened independently by two reviewers (SZ and LT) based on inclusion and exclusion criteria. The same reviewers will then assess the full text of articles that passed the first step of screening to ensure eligibility criteria are met. Two reviewers will meet regularly to discuss progress and potential difficulties. Any discrepancies between reviewers will be resolved by discussion or consultation with clinical and research experts (NC and AC). We will present the process of study selection in the flowchart format. The rational for excluding articles from systematic review will be reported in a separate table. Both reviewers will participate in the pilot study exercise on the first 100 articles to discuss possible challenges." (Page 6) Details of information that will be extracted from each study were reported in the "data extraction" section. (page6) -There needs to be a greater elaboration of what missing information would be requested from authors. I would change "missing data" to "missing methodological information".
Answers: The title of this section is changed from "missing data" to "Missing Methodological Information" and more explanation was provided accordingly. "For studies with missing data, the corresponding author will be contacted for further explanation on any important missing information such as definition of the proposed discharge destination, predictors and methodology of study". (Page 7) -The authors state that meta-analysis won"t be used due to the heterogeneity in studies. It is unclear to me how heterogeneity would be a problem. If samples are used that have moderate and low levels of bias but somewhat different characteristics, meta-analysis would help pool these samples and produce a more reliable result. Heterogeneity of effect size or precision could impact the modeling approach used but wouldn"t be a deterrent to using meta-analysis.
Answers: We will take your comment into consideration. If sufficient data are available on predictors of discharge destination (i.e., age, sex, injury, severity, insurance status, etc.), data will be combined and analyzed simultaneously and whenever possible combined results will be reported. In the case of insufficient data on predictors, findings will be integrated for each objective through tabulation and qualitative description as an alternative of meta-analysis described by Slavin RE (1995).
The following paragraph has been added to the manuscript: "If sufficient data are available on each predictors of discharge destination, data will be combined and analyzed simultaneously and whenever possible pooled results will be reported. In the case of insufficient data on predictors, findings will be integrated for each objective through tabulation and qualitative description will be provided for predictors of discharge destination (37)". (page 8).
Reference #37 was added for this section (page 13)
Also, we will report a phase of explanatory prognosis investigation described by Hyden et al in 2008 for each predictor as below (explained in the presenting and reporting the results section). (page8) "We will report a percentage and frequency of studies that were conducted on each predictor. All evidence will be reported using three phases of explanatory prognosis investigation described by Hyden et al (38) . These three phases include: Identifying association (Phase I), testing independent association (Phase II) and understanding prognostic pathway (Phase III). While Phase I evidence identifies associations between various potential prognostic factors and a health outcome, Phase II studies examine the independence of the association between a prognostic factor and the outcome of interest while controlling for confounding factors. Phase III studies describe the complexity of the prognostic pathways or processes. The direction of association will be coded with (+) for positive direction, (-) for negative direction and (0) for lack of association. Additionally, the quality of studies for each predictor will be reported in three categories based on result of quality assessment". Reference #38 was added for this section (page13) -The authors are using the QUIPS to evaluate bias in prognostic studies. The use of QUIPS really requires having statistical expertise on the SR panel and pre-specification of high, medium, and low bias methods for the type of prognostic questions and statistical analyses used. For example, some thought or documentation of thought already given needs to be provided on requirements for study power and evaluating single factor models versus factors in multivariable models. Will articles using stepwise regression be included given their common use in rehabilitation but their notorious 40% false positive predictor identification rates and inflated ORs (and low CI"s).
Answer: We will take this comment in to consideration by obtaining consultation from a bio-statistician to decide which variables can be pooled for meta-analysis. Also, we will use three phases of explanatory prognosis investigation described by Hyden et al. (as mentioned above) to identify the phase of prognostic studies based on their methodology of statistical analysis of predictors.
Regarding the type of regression, we will report the methodology of analysis of data in a data extraction table for each article and will discuss the limitations of included articles with respect to their methodology of analysis.
-Having read the whole article now, my sense is that the author team only partially has the expertise required to successfully conduct this SR. A biostatistician with expertise in multivariable logistic regression and meta-analysis is an absolute requirement. This SR cannot be done successfully without this expertise throughout the SR process. Also, this SR is about how decisions are made in an acute care environment. There does not appear to be acute care discharge decision makers, e.g., trauma MD"s or case managers (preferable with SR experience), on the project. Such decisionmaking expertise is crucial to interpreting data and drawing conclusions from the evidence.
Answer: We will consult with a bio-statistician with expertise in meta-analysis to decide which variables have the potential to be included in further statistical analysis. This research has been initiated by multidisciplinary team with such substantial clinical and research experience working with patients with TBI around their pathway of care includes a physiatrist (NC), an epidemiologist (AC), a physician (LT) and an occupational therapist (SZ) who will be contributed to the concept and initiation of this systematic review.
* All changes are highlighted in the text of the manuscript. 
GENERAL COMMENTS
Thanks to the authors for considering the recommendations in the original review. Many of the recommendations were incorporated into the SR design and plan. The Hayden 2008 article on phases for explanatory models was a nice addition.
There are still two issues that require attention. I was surprised and honestly disappointed to not see several acute care specialists and at least one biostatistician added to the study author team. In reading the conclusion below, the reach of how these findings are intended for use far exceed the expertise on the SR team. This is not in any way a negative reflection on the vast experience of the author team on matters of inpatient and outpatient rehabilitation. But if the goal of this paper is to "help health care providers to design more accurate and realistic care and referral plans", help "patients will transition to the next level of care in a more timely way and with lower cost", "develop and plan new policies", and provide "necessary elements to develop referral/discharge guideline for patients with TBI", you Conclusion cut and pasted To our knowledge, this study will be the first systematic review on predictors of discharge destinations from acute care in patients with TBI. Recognizing predictors of discharge destination early in the recovery period of acute care will help health care providers to design more accurate and realistic care and referral plans. In addition, health care providers can inform patients and their families of the most likely discharge destination so that they can prepare themselves for potential changes in living location. Thus, patients will transition to the next level of care in a more timely way and with lower cost, which will lead to improved quality of care for TBI patients. The results of this study may provide reliable evidence for governments and policy makers to prioritize their support, develop and plan new policies to patients with TBI and researchers. Researchers also will be informed of the current gaps of knowledge in this area and necessary elements to develop referral/discharge guideline for patients with TBI.
REVIEWER
Keith O. Yeates University of Calgary, Canada REVIEW RETURNED 05-Jun-2017
GENERAL COMMENTS
The authors have provided a satisfactory response to the previous review. I have no further concerns.
VERSION 2 -AUTHOR RESPONSE
Thank you for your comments. We have taken your suggestions into consideration and have responded below.
"There are still two issues that require attention. I was surprised and honestly disappointed to not see several acute care specialists and at least one biostatistician added to the study author team. In reading the conclusion below, the reach of how these findings are intended for use far exceed the expertise on the SR team. This is not in any way a negative reflection on the vast experience of the author team on matters of inpatient and outpatient rehabilitation. But if the goal of this paper is to "help health care providers to design more accurate and realistic care and referral plans", help "patients will transition to the next level of care in a more timely way and with lower cost", "develop and plan new policies", and provide "necessary elements to develop referral/discharge guideline for patients with TBI", you have to have acute care expertise on your panel. It really borders on being an ethical issue. I'm really trying to be helpful with this recommendation. Further, understanding the complexity of regression studies including appropriate analyses used, assumptions tested, power for explanatory predictors versus power for an adequate model, use of appropriate validation and performance measures all require biostatistical expertise in order to rate study quality. Nonstatisticians won't have the expertise. I hope this advice is accepted in the positive spirit in which it is provided. Best wishes with your SR".
-We wish to respond to the reviewer"s concern of limited expertise with data relevant to acute care:
